VOCO introduces CleanJoy, a fluoride and xylitol-containing, minimally abrasive prophy paste.

A significant adverse reaction was noted in one participant of a clinical trial on a COVID-19 vaccine being developed by AstraZeneca in partnership with Oxford University.

ErgoFinger® wearable high-volume evacuation device reduces physical stress as well as aerosol contamination.

The National Institute on Aging, part of the National Institutes of Health (NIH), has awarded a grant to researchers at New York University College of Dentistry (NYU Dentistry) to explore age-related, chronic low-grade inflammation and…

Kathleen T. O’Loughlin, DMD, MPH, executive director of the American Dental Association, asked members of a National Academies, Engineering, and Medicine panel—who are working on a plan for the equitable distribution of COVID-19 vaccines—to…

Katrina Virgin, RDH, MS, shares her insights on providing oral health care in the remote regions of Alaska during a global pandemic.

While international travel may not be top-of-mind for most right now, many oral health professionals volunteer their time and expertise on dental mission trips. But how effective are these outreach programs?

The novel coronavirus pandemic has changed the landscape of our lives for the time being. But what is the overall impact of COVID-19 on 21st-century dentistry?

While the United States has spent more than $10 billion on vaccine development, funds have not been allocated to support public health departments in rolling out two COVID-19 vaccines that may be ready as early as late October or the…

Approximately 69% of COVID-19 infections went undiagnosed among 3,000 frontline healthcare professionals between April and June in 12 states, according to new research published in the United States Morbidity and Mortality Weekly Report.…